SlideShare ist ein Scribd-Unternehmen logo
1 von 26
We are over 10,000
voices strong
The IAS is the world’s largest association of HIV
professionals. Together we advocate and drive urgent
action to reduce the global impact of HIV across every
front of the response. Join the movement, become an
IAS member today!
Abstract Submission is open from
1 December 2015 - 4 February 2016
State of the Science:
Key Populations
Chris Beyrer MD, MPH
President, The International AIDS Society
Key Populations in HIV
Key populations: those individuals and communities who have
disproportionate burdens of HIV risk and disease and lack of
access to essential HIV services
• Gay, Bisexual, and other men who have sex with men
(MSM)
• Sex Workers of all genders
• People who inject drugs (PWID)
• Transgender Women who have sex with men
• Women and Girls in South, East African hyper-epidemics
• Adolescents from all of these communities
Global Prevalence of HIV in PWID
Worldwide were an estimated 12.7 million PWID in 2014: 1.7 million
living with HIV (some 13% all HIV cases)
In Greece there were: 2000-2010, 9-19 new HIV
cases in IDU (2%–3% of all cases); in 2011, 266
cases in IDU ( 28% of HIV cases) and in 2012, 547
cases in IDU (46% of HIV cases)
HIV can Disseminate very rapidly among PWID
Outbreak of HIV Linked to
Oxymorphone in Indiana,
USA, 2015
80%
3%
17%
Injection Drug Use
No Injection Drug Use
Not Interviewed to
Determine Status
Average 9 syringe-sharing
partners, sex partners
Outbreak of HIV in
Greece and Romania
In Scott County, which is a community of
4200 people there have been 173 new HIV
Infections since January of 2015
Global HIV prevalence among adult women
sex workers, 2013.
Beyrer, et al, The Lancet, 2014.
Global HIV prevalence among adult women
sex workers, 2013.
Beyrer, et al, The Lancet, 2014.
HIV prevalence among transgender women,
2000-2011 Baral, Poteat, Beyrer LID, 2013
Pooled OR for HIV infection among TGW compared to
other reproductive people: 48.8 (95% CI 31.2-76.3)
Global HIV incidence among MSM to 2014
Diagnoses of HIV Infection among Adult and Adolescent Males, by
Transmission Category, 2010-2014
United States and 6 Dependent Areas
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statisticallyadjusted to account for reportingdelays and missing transmission category, but not for incomplete reporting.
a Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
b Includes hemophilia,blood transfusion, perinatalexposure, and risk factor not reported or identified.
Diagnoses of HIV Infection among Adults and Adolescents,
by Race/Ethnicity, 2010–2014—United States and
6 Dependent Areas
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically
adjusted to account for reporting delays, but not for incomplete reporting.
a Hispanics/Latinos can be of any race.
Continuum of Care, Young MSM
353
181
145 140
100
59
0
50
100
150
200
250
300
350
0
20
40
60
80
100
HIV Infected HIV Diagnosed Linked to HIV
Care
Retained in
HIV Care
On ART Suppressed VL
Percentage
Engagement in HIV Care
Estimated number and percentage of HIV infected men who have sex with
men age 13-24 engaged in selected stages of the continuum of care,
Baltimore City, 2013
Using data as reported through 12/31/2014
The Work Undone
Lack of Access
to essential services
Variable
Fear of Seeking Health Care OR
(95% CI)
Denied Health Care Services
OR (95% CI)
Blackmailed
OR (95% CI)
Diagnosed with an STI 2.4 (1.4-4.3) * 6.9 (3.0-15.6) ** 1.5 (0.8-2.7)
Treated for an STI 2.8 (1.7-4.9) ** 7.3 (3.3-16.2) ** 1.5 (0.8-2.6)
Received recommendation for
an HIV test
1.9 (1.2-3.0) * 2.2 (0.98-4.8) 1.8 (1.1-2.8) *
Ever tested for HIV 1.1 (0.7-1.7) 1.6 (0.7-3.7) 1.0 (0.7-1.6)
Self-Reported Diagnosis of HIV
or AIDS
2.6 (1.1-6.5) * 3.3 (0.9-12.1) 2.7 (1.1-6.6) *
Self-Reported Treatment for
HIV
3.7 (1.6-8.6) * 46.1 (17.3-122.8) ** 5.4 (2.2-13.2) **
HIV positive 1.7 (0.9-3.2) 1.2 (0.4-3.6) 0.9 (0.5-1.6)
Any interaction with health
care
2.6 (1.6-3.9) ** 6.4 (2.5-16.1) ** 2.1 (1.4-3.2) *
Pooled Data from Three Countries
* - p <0.05
** - p <0.01
Source: Fay H, Baral S, Trapence G, Motimedi F, Umar E, et al. Stigma, Health Care Access, and HIV Knowledge Among Men Who Have Sex With Men in Malawi, Namibia, and Botswana. AIDS and Behavior, Dec
2010: 1-10.
Associations between fear and experienced discrimination with sexual health
and use of services among MSM in Malawi, Botswana, and Namibia.
Effects of the Criminalization of Same-
Sex Practices in Nigeria
• Same-sex marriage bill introduced in Nigeria in January, 2014
further criminalizing same-sex relationships and associations with
community groups
• Methods
– MSM recruited through respondent-driven sampling and enrolled into
a prospective cohort in Abuja from March 2013-June 2014
– Characteristics related to discrimination and HIV care are described
and compared pre-post legislation using chi-squared statistics
– TRUST Model
• UMD/IHV HIV Prevention and Treatment Services co-located with community
group serving MSM (ICARH)
Sources: Schwartz, Nowak, Orazulike, Blattner, Charurat, Baral, TRUST Study Group (UMD, MHRP, ICARH, JHU). The immediate HIV-related impact of
enacted legislation that further criminalizes same-sex practices in Nigeria. Forthcoming
Outcomes of Criminalization on HIV-
Risks among MSM in Nigeria
 Reporting of Discrimination and Stigma
During Study Visits Pre and Post Legislation
 Cumulative lifetime experiences of reported
fear of seeking health care services across
study visits (n=1,175 visits).
Sources: Schwartz, Nowak, Orazulike, Blattner, Charurat, Baral, TRUST Study Group (UMD, MHRP, ICARH, JHU). The immediate HIV-related impact of
enacted legislation that further criminalizes same-sex practices in Nigeria. Forthcoming
Source: Bureau of Justice Statistics, 2009
ADULTS (+7M)
> 5.5M need SUD TX
JUVENILES (650K)
253,034 need SUD TX
14% of all people in
the US with HIV pass
through a correctional
facility per year
Incarceration Predicts Virologic
Failure for
HIV + PWID Receiving ART
Westergaard RP et al., HIV/AIDS 2011; 53: 725-731.
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
No incarceration Incarceration during
prior 6 months
Had clinic visit
got ART
Clinic visit,
did not get ART
Got ART,
no clinic visit
Did not get ART,
no clinic visit
The Global Fund in Transition
• Since 2002 the Global Fund to Fight AIDS, Tuberculosis and Malaria has
mobilized more than 40 billion USD
• A funding crisis after its 10th round forced the GF board into announcing a new
approach
• The New Funding Model rolled out in 2014 uses an eligibility formula based on
national income and disease burden prioritizing lower-middle income countries
• Middle-income countries (MICs) receive much lower levels of GF support
• The burden HIV/TB is actually concentrated in MICs, with approximately 57% of
AIDS, 72% of TB, and 54% of malaria in MICs
• Three of the top five countries with the highest HIV burdens are middle income
and eight of the ten countries with the highest TB burdens are middle income
• Key Populations most affected—outside Africa, predominance of HIV is in KP
Source:A. Klepikov, International HIV/AIDS Alliance in Ukraine presentation, Barcelona meeting available at
https://www.opensocietyfoundations.org/sites/default/files/global-fund-crossroads-20150611.pdf
Predicted impact of GF transition on GF and Government funding in Ukraine
Source:A. Klepikov, International HIV/AIDS Alliance in Ukraine presentation, Barcelona meeting available at
https://www.opensocietyfoundations.org/sites/default/files/global-fund-crossroads-20150611.pdf
Insurer Says Clients on Daily Pill
Have Stayed H.I.V.-Free
The New York times
DONALD G. McNEIL Jr. SEPT. 2, 2015
No New HIV Infections with Increasing Use of HIV
Preexposure Prophylaxis in a Clinical Practice Setting
Jonathan E. Volk, J Marcus, T Phengrasamy, D Blechinger, DP Nguyen, Follansbee, and C.
Hare. Clinical Infectious Diseases, Sept. 2, 2015.
Abstract
Referrals for and initiation of pre-exposure prophylaxis (PrEP) for HIV
infection increased dramatically in a large clinical practice setting
since 2012. Despite high rates of sexually transmitted infections
among PrEP users and reported decreases in condom use in a subset,
there were no new HIV infections in this population.
657 people, followed over 36 months, 388/person years of
observation
99% MSM
PrEP Efficacy Trials, Oral and Topical
Research Agenda
• Reducing incidence: PrEP implementation for Key
Populations
• Optimizing Treatment: MSM, PWID, SW, TG need
HIV testing, ARVs, PrEP platforms in safety and
dignity
• Tailored interventions across the continuum
needed to address LGBT health disparities
globally
• Next generation interventions and delivery
systems need to be designed for KP to achieve
control of HIV
Acknowledgements
Johns Hopkins
Stefan Baral, Tonia Poteat, Sheree
Schwartz, Brian Weir, Andrea Wirtz,
Anne Efron, Liz Bonomo, Richard
Chaisson, Nick
Sex Workers and HIV
Linda-Gail Bekker, Jenny Butler, Anna-
Louise Crago, Pam Das, Leigh
Johnson, Kate Shannon, Steffanie
Strathdee, Frances Cowan, Cheryl
Overs, Donela Besada, Sharon Hillier,
Ward Cates
Meg Doherty, Bob Grant, Gottfried
Hirnshchall, Michel Kazatchkine, Ken
Mayer, Owen Ryan, Michel Sidibe,
Nora Volkov
MSM Prevention: Patrick
Sullivan, Alex Carballo-Dieguez,
Thomas Coates, Steven M
Goodreau, Sybil Hosek, Ian
McGowan, Eduard J Sanders,
Adrian Smith, P. Goswami, Jorge
Sanchez
MSM Epidemiology
Frits van Griensven, Steven
Goodreau, Suwat Chariyalertsak,
Ron Brookmeyer, Pat Chaulk
Supported by grants to the Center for Public Health and Human Rights at John Hopkins from
amfAR the Foundation for AIDS Research
The Bill & Melinda Gates Foundation
Project Search, USAID
The John Hopkins Center for AIDS Research (NIAID, 1P30AI094189-01A1)

Weitere ähnliche Inhalte

Was ist angesagt?

PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
StopTb Italia
 
01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work
01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work
01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work
Nicholas Jacobs
 

Was ist angesagt? (20)

04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
 
HIV NACO guideline latest 2018
HIV NACO guideline latest 2018HIV NACO guideline latest 2018
HIV NACO guideline latest 2018
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
 
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work
01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work
01 Setswe~Hiv Prevention Where Is The Evidence Of Interventions That Work
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
 
Burden of HIV and Research Gaps Among Key Populations in Sub-Saharan Africa
Burden of HIV and Research Gaps Among Key Populations in Sub-Saharan AfricaBurden of HIV and Research Gaps Among Key Populations in Sub-Saharan Africa
Burden of HIV and Research Gaps Among Key Populations in Sub-Saharan Africa
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
 
Naco
NacoNaco
Naco
 
Hiv aids in india
Hiv  aids in indiaHiv  aids in india
Hiv aids in india
 
Game Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanGame Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari Ngadiman
 
Recent advances in HIV/AIDS
Recent advances in HIV/AIDSRecent advances in HIV/AIDS
Recent advances in HIV/AIDS
 
HIVScreeningApproved
HIVScreeningApprovedHIVScreeningApproved
HIVScreeningApproved
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
Fsrh hc hiv phillips
Fsrh hc hiv phillipsFsrh hc hiv phillips
Fsrh hc hiv phillips
 
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen BradyThe HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
 
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan BaralHIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan Baral
 

Ähnlich wie Chris Beyrer: "State of the Science: Key populations"

hiv-aidsinindia-140429233232-phpapp02.pdf
hiv-aidsinindia-140429233232-phpapp02.pdfhiv-aidsinindia-140429233232-phpapp02.pdf
hiv-aidsinindia-140429233232-phpapp02.pdf
KarthikUndamatla3
 
HIVinterventionstrategy
HIVinterventionstrategyHIVinterventionstrategy
HIVinterventionstrategy
Kelly Garcia
 

Ähnlich wie Chris Beyrer: "State of the Science: Key populations" (20)

HIV Winnable Battle presentation
HIV Winnable Battle presentationHIV Winnable Battle presentation
HIV Winnable Battle presentation
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girls
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen BradyThe HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
 
Attitude of the youth towards voluntary counselling and testing (vct) of hiv ...
Attitude of the youth towards voluntary counselling and testing (vct) of hiv ...Attitude of the youth towards voluntary counselling and testing (vct) of hiv ...
Attitude of the youth towards voluntary counselling and testing (vct) of hiv ...
 
Bending the Curve: PrEP for HIV Prevention
Bending the Curve: PrEP for HIV PreventionBending the Curve: PrEP for HIV Prevention
Bending the Curve: PrEP for HIV Prevention
 
HATS_Medwiser_A
HATS_Medwiser_AHATS_Medwiser_A
HATS_Medwiser_A
 
HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairies
 
Where are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gapsWhere are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gaps
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
hiv-aidsinindia-140429233232-phpapp02.pdf
hiv-aidsinindia-140429233232-phpapp02.pdfhiv-aidsinindia-140429233232-phpapp02.pdf
hiv-aidsinindia-140429233232-phpapp02.pdf
 
HIVinterventionstrategy
HIVinterventionstrategyHIVinterventionstrategy
HIVinterventionstrategy
 
Hiv &amp;ictc seminar by Dr. Mousumi Sarkar
Hiv &amp;ictc seminar by Dr. Mousumi SarkarHiv &amp;ictc seminar by Dr. Mousumi Sarkar
Hiv &amp;ictc seminar by Dr. Mousumi Sarkar
 
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
 
Embargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbellEmbargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbell
 
2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady
 
Journal.pone.0035278
Journal.pone.0035278Journal.pone.0035278
Journal.pone.0035278
 
Journal.pone.0035278
Journal.pone.0035278Journal.pone.0035278
Journal.pone.0035278
 
Anal Cytology and Anal Cancer Screening in HIV Patients
Anal Cytology and Anal Cancer Screening in HIV PatientsAnal Cytology and Anal Cancer Screening in HIV Patients
Anal Cytology and Anal Cancer Screening in HIV Patients
 

Mehr von HopkinsCFAR

Mehr von HopkinsCFAR (20)

NIH AIDS Executive Committee (NAEC) FY 2019 Ending the HIV Epidemic (EHE) in ...
NIH AIDS Executive Committee (NAEC) FY 2019 Ending the HIV Epidemic (EHE) in ...NIH AIDS Executive Committee (NAEC) FY 2019 Ending the HIV Epidemic (EHE) in ...
NIH AIDS Executive Committee (NAEC) FY 2019 Ending the HIV Epidemic (EHE) in ...
 
Baltimore mapping studies working copy 27 oct2021
Baltimore mapping studies working copy 27 oct2021Baltimore mapping studies working copy 27 oct2021
Baltimore mapping studies working copy 27 oct2021
 
HIV National Strategic Plan 2021-2025
HIV National Strategic Plan 2021-2025HIV National Strategic Plan 2021-2025
HIV National Strategic Plan 2021-2025
 
Research Fundamentals for Activists
Research Fundamentals for ActivistsResearch Fundamentals for Activists
Research Fundamentals for Activists
 
Test masterfile baltimore hiv studies
Test masterfile baltimore hiv studiesTest masterfile baltimore hiv studies
Test masterfile baltimore hiv studies
 
EHE Plan Baltimore City v2.0 dec 22 2020
EHE Plan Baltimore City v2.0 dec 22 2020EHE Plan Baltimore City v2.0 dec 22 2020
EHE Plan Baltimore City v2.0 dec 22 2020
 
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
 
NIMH funding on PrEP use Among Adolescent Girls and Young Women in sub-Sahara...
NIMH funding on PrEP use Among Adolescent Girls and Young Women in sub-Sahara...NIMH funding on PrEP use Among Adolescent Girls and Young Women in sub-Sahara...
NIMH funding on PrEP use Among Adolescent Girls and Young Women in sub-Sahara...
 
Getting to Zero San Francisco
Getting to Zero San FranciscoGetting to Zero San Francisco
Getting to Zero San Francisco
 
Testing for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ARTTesting for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ART
 
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
 
The HIV Prevention Product Pipeline for Adolescents
The HIV Prevention Product Pipeline for AdolescentsThe HIV Prevention Product Pipeline for Adolescents
The HIV Prevention Product Pipeline for Adolescents
 
New NIH Funded Research to Advance Oral PrEP Use and Delivery
New NIH Funded Research to Advance Oral PrEP Use and DeliveryNew NIH Funded Research to Advance Oral PrEP Use and Delivery
New NIH Funded Research to Advance Oral PrEP Use and Delivery
 
High Sensitivity HIV Testing and Translational Science around PrEP
High Sensitivity HIV Testing and Translational Science around PrEPHigh Sensitivity HIV Testing and Translational Science around PrEP
High Sensitivity HIV Testing and Translational Science around PrEP
 
Adaptation of Evidence-based Interventions and De-Implementation of Ineffecti...
Adaptation of Evidence-based Interventions and De-Implementation of Ineffecti...Adaptation of Evidence-based Interventions and De-Implementation of Ineffecti...
Adaptation of Evidence-based Interventions and De-Implementation of Ineffecti...
 
Innovative Study Designs for Implementation Research
Innovative Study Designs for Implementation ResearchInnovative Study Designs for Implementation Research
Innovative Study Designs for Implementation Research
 
Research Priorities for Differentiated Care
Research Priorities for Differentiated CareResearch Priorities for Differentiated Care
Research Priorities for Differentiated Care
 
HIV Behavioral Surveillance Baltimore: The BESURE Study
HIV Behavioral Surveillance Baltimore: The BESURE StudyHIV Behavioral Surveillance Baltimore: The BESURE Study
HIV Behavioral Surveillance Baltimore: The BESURE Study
 
The AIDS Linked to the IntraVenous Experience (ALIVE) Study
The AIDS Linked to the IntraVenous Experience (ALIVE) StudyThe AIDS Linked to the IntraVenous Experience (ALIVE) Study
The AIDS Linked to the IntraVenous Experience (ALIVE) Study
 
Providing Safe, Affirming and Evidence Based Care for Transgender Persons: Pa...
Providing Safe, Affirming and Evidence Based Care for Transgender Persons: Pa...Providing Safe, Affirming and Evidence Based Care for Transgender Persons: Pa...
Providing Safe, Affirming and Evidence Based Care for Transgender Persons: Pa...
 

Kürzlich hochgeladen

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Kürzlich hochgeladen (20)

Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 

Chris Beyrer: "State of the Science: Key populations"

  • 1. We are over 10,000 voices strong The IAS is the world’s largest association of HIV professionals. Together we advocate and drive urgent action to reduce the global impact of HIV across every front of the response. Join the movement, become an IAS member today!
  • 2. Abstract Submission is open from 1 December 2015 - 4 February 2016
  • 3. State of the Science: Key Populations Chris Beyrer MD, MPH President, The International AIDS Society
  • 4. Key Populations in HIV Key populations: those individuals and communities who have disproportionate burdens of HIV risk and disease and lack of access to essential HIV services • Gay, Bisexual, and other men who have sex with men (MSM) • Sex Workers of all genders • People who inject drugs (PWID) • Transgender Women who have sex with men • Women and Girls in South, East African hyper-epidemics • Adolescents from all of these communities
  • 5. Global Prevalence of HIV in PWID Worldwide were an estimated 12.7 million PWID in 2014: 1.7 million living with HIV (some 13% all HIV cases)
  • 6. In Greece there were: 2000-2010, 9-19 new HIV cases in IDU (2%–3% of all cases); in 2011, 266 cases in IDU ( 28% of HIV cases) and in 2012, 547 cases in IDU (46% of HIV cases) HIV can Disseminate very rapidly among PWID Outbreak of HIV Linked to Oxymorphone in Indiana, USA, 2015 80% 3% 17% Injection Drug Use No Injection Drug Use Not Interviewed to Determine Status Average 9 syringe-sharing partners, sex partners Outbreak of HIV in Greece and Romania In Scott County, which is a community of 4200 people there have been 173 new HIV Infections since January of 2015
  • 7. Global HIV prevalence among adult women sex workers, 2013. Beyrer, et al, The Lancet, 2014.
  • 8. Global HIV prevalence among adult women sex workers, 2013. Beyrer, et al, The Lancet, 2014.
  • 9. HIV prevalence among transgender women, 2000-2011 Baral, Poteat, Beyrer LID, 2013 Pooled OR for HIV infection among TGW compared to other reproductive people: 48.8 (95% CI 31.2-76.3)
  • 10. Global HIV incidence among MSM to 2014
  • 11. Diagnoses of HIV Infection among Adult and Adolescent Males, by Transmission Category, 2010-2014 United States and 6 Dependent Areas Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statisticallyadjusted to account for reportingdelays and missing transmission category, but not for incomplete reporting. a Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. b Includes hemophilia,blood transfusion, perinatalexposure, and risk factor not reported or identified.
  • 12. Diagnoses of HIV Infection among Adults and Adolescents, by Race/Ethnicity, 2010–2014—United States and 6 Dependent Areas Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically adjusted to account for reporting delays, but not for incomplete reporting. a Hispanics/Latinos can be of any race.
  • 13. Continuum of Care, Young MSM 353 181 145 140 100 59 0 50 100 150 200 250 300 350 0 20 40 60 80 100 HIV Infected HIV Diagnosed Linked to HIV Care Retained in HIV Care On ART Suppressed VL Percentage Engagement in HIV Care Estimated number and percentage of HIV infected men who have sex with men age 13-24 engaged in selected stages of the continuum of care, Baltimore City, 2013 Using data as reported through 12/31/2014
  • 14. The Work Undone Lack of Access to essential services
  • 15. Variable Fear of Seeking Health Care OR (95% CI) Denied Health Care Services OR (95% CI) Blackmailed OR (95% CI) Diagnosed with an STI 2.4 (1.4-4.3) * 6.9 (3.0-15.6) ** 1.5 (0.8-2.7) Treated for an STI 2.8 (1.7-4.9) ** 7.3 (3.3-16.2) ** 1.5 (0.8-2.6) Received recommendation for an HIV test 1.9 (1.2-3.0) * 2.2 (0.98-4.8) 1.8 (1.1-2.8) * Ever tested for HIV 1.1 (0.7-1.7) 1.6 (0.7-3.7) 1.0 (0.7-1.6) Self-Reported Diagnosis of HIV or AIDS 2.6 (1.1-6.5) * 3.3 (0.9-12.1) 2.7 (1.1-6.6) * Self-Reported Treatment for HIV 3.7 (1.6-8.6) * 46.1 (17.3-122.8) ** 5.4 (2.2-13.2) ** HIV positive 1.7 (0.9-3.2) 1.2 (0.4-3.6) 0.9 (0.5-1.6) Any interaction with health care 2.6 (1.6-3.9) ** 6.4 (2.5-16.1) ** 2.1 (1.4-3.2) * Pooled Data from Three Countries * - p <0.05 ** - p <0.01 Source: Fay H, Baral S, Trapence G, Motimedi F, Umar E, et al. Stigma, Health Care Access, and HIV Knowledge Among Men Who Have Sex With Men in Malawi, Namibia, and Botswana. AIDS and Behavior, Dec 2010: 1-10. Associations between fear and experienced discrimination with sexual health and use of services among MSM in Malawi, Botswana, and Namibia.
  • 16. Effects of the Criminalization of Same- Sex Practices in Nigeria • Same-sex marriage bill introduced in Nigeria in January, 2014 further criminalizing same-sex relationships and associations with community groups • Methods – MSM recruited through respondent-driven sampling and enrolled into a prospective cohort in Abuja from March 2013-June 2014 – Characteristics related to discrimination and HIV care are described and compared pre-post legislation using chi-squared statistics – TRUST Model • UMD/IHV HIV Prevention and Treatment Services co-located with community group serving MSM (ICARH) Sources: Schwartz, Nowak, Orazulike, Blattner, Charurat, Baral, TRUST Study Group (UMD, MHRP, ICARH, JHU). The immediate HIV-related impact of enacted legislation that further criminalizes same-sex practices in Nigeria. Forthcoming
  • 17. Outcomes of Criminalization on HIV- Risks among MSM in Nigeria  Reporting of Discrimination and Stigma During Study Visits Pre and Post Legislation  Cumulative lifetime experiences of reported fear of seeking health care services across study visits (n=1,175 visits). Sources: Schwartz, Nowak, Orazulike, Blattner, Charurat, Baral, TRUST Study Group (UMD, MHRP, ICARH, JHU). The immediate HIV-related impact of enacted legislation that further criminalizes same-sex practices in Nigeria. Forthcoming
  • 18. Source: Bureau of Justice Statistics, 2009 ADULTS (+7M) > 5.5M need SUD TX JUVENILES (650K) 253,034 need SUD TX 14% of all people in the US with HIV pass through a correctional facility per year Incarceration Predicts Virologic Failure for HIV + PWID Receiving ART Westergaard RP et al., HIV/AIDS 2011; 53: 725-731. 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% No incarceration Incarceration during prior 6 months Had clinic visit got ART Clinic visit, did not get ART Got ART, no clinic visit Did not get ART, no clinic visit
  • 19. The Global Fund in Transition • Since 2002 the Global Fund to Fight AIDS, Tuberculosis and Malaria has mobilized more than 40 billion USD • A funding crisis after its 10th round forced the GF board into announcing a new approach • The New Funding Model rolled out in 2014 uses an eligibility formula based on national income and disease burden prioritizing lower-middle income countries • Middle-income countries (MICs) receive much lower levels of GF support • The burden HIV/TB is actually concentrated in MICs, with approximately 57% of AIDS, 72% of TB, and 54% of malaria in MICs • Three of the top five countries with the highest HIV burdens are middle income and eight of the ten countries with the highest TB burdens are middle income • Key Populations most affected—outside Africa, predominance of HIV is in KP
  • 20. Source:A. Klepikov, International HIV/AIDS Alliance in Ukraine presentation, Barcelona meeting available at https://www.opensocietyfoundations.org/sites/default/files/global-fund-crossroads-20150611.pdf
  • 21. Predicted impact of GF transition on GF and Government funding in Ukraine Source:A. Klepikov, International HIV/AIDS Alliance in Ukraine presentation, Barcelona meeting available at https://www.opensocietyfoundations.org/sites/default/files/global-fund-crossroads-20150611.pdf
  • 22. Insurer Says Clients on Daily Pill Have Stayed H.I.V.-Free The New York times DONALD G. McNEIL Jr. SEPT. 2, 2015
  • 23. No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting Jonathan E. Volk, J Marcus, T Phengrasamy, D Blechinger, DP Nguyen, Follansbee, and C. Hare. Clinical Infectious Diseases, Sept. 2, 2015. Abstract Referrals for and initiation of pre-exposure prophylaxis (PrEP) for HIV infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population. 657 people, followed over 36 months, 388/person years of observation 99% MSM
  • 24. PrEP Efficacy Trials, Oral and Topical
  • 25. Research Agenda • Reducing incidence: PrEP implementation for Key Populations • Optimizing Treatment: MSM, PWID, SW, TG need HIV testing, ARVs, PrEP platforms in safety and dignity • Tailored interventions across the continuum needed to address LGBT health disparities globally • Next generation interventions and delivery systems need to be designed for KP to achieve control of HIV
  • 26. Acknowledgements Johns Hopkins Stefan Baral, Tonia Poteat, Sheree Schwartz, Brian Weir, Andrea Wirtz, Anne Efron, Liz Bonomo, Richard Chaisson, Nick Sex Workers and HIV Linda-Gail Bekker, Jenny Butler, Anna- Louise Crago, Pam Das, Leigh Johnson, Kate Shannon, Steffanie Strathdee, Frances Cowan, Cheryl Overs, Donela Besada, Sharon Hillier, Ward Cates Meg Doherty, Bob Grant, Gottfried Hirnshchall, Michel Kazatchkine, Ken Mayer, Owen Ryan, Michel Sidibe, Nora Volkov MSM Prevention: Patrick Sullivan, Alex Carballo-Dieguez, Thomas Coates, Steven M Goodreau, Sybil Hosek, Ian McGowan, Eduard J Sanders, Adrian Smith, P. Goswami, Jorge Sanchez MSM Epidemiology Frits van Griensven, Steven Goodreau, Suwat Chariyalertsak, Ron Brookmeyer, Pat Chaulk Supported by grants to the Center for Public Health and Human Rights at John Hopkins from amfAR the Foundation for AIDS Research The Bill & Melinda Gates Foundation Project Search, USAID The John Hopkins Center for AIDS Research (NIAID, 1P30AI094189-01A1)